The Human Operating Manual

Psychedelics & Ego Dissolution

Contents

I. What Is Actually Happening: the Entropic Brain

II. The Compounds

III. The Promise

IV. The Risks

V. Use, Not Abuse

VI. The Ego Death Trap

VII. Cross-Links

Is your awakening real, or are you just chemically unburdened?

Psychedelics, used carefully, can be among the most powerful tools a human being has ever found for changing a stuck mind: for loosening depression and addiction that nothing else has been able to, for resolving grief and trauma, for dissolving the fear of death, and for occasioning experiences that people rank, decades later, among the most meaningful of their lives. People are going to explore this territory regardless of what any website says, which means the responsible thing is not to chant “it’s illegal, don’t,” but to map the terrain, the mechanisms, and the risks, so that anyone who goes in does so with knowledge.

A psychedelic experience can be a doorway, and it can also be a chemically-generated certainty signifying nothing, and the compound itself cannot tell you which. When you come down convinced you have awakened, did something true and lasting actually change, or were you simply, for a few hours, unburdened of the self that was doing the suffering? Only one of them changes your life, and which one it becomes is decided not during the experience but in the integrative weeks and years after it.

 

I. What Is Actually Happening: the Entropic Brain

The dominant model, developed by Robin Carhart-Harris and colleagues, is the entropic brain hypothesis and its successor, REBUS (Relaxed Beliefs Under Psychedelics).

The ordinary adult brain, in this account, is a prediction machine that runs on low entropy. To navigate the world efficiently, it builds a tight model of reality from prior experience, a set of high-level assumptions, beliefs, and habits (technically, priors) that constrain what it expects and perceives, and it spends energy holding that model rigid and orderly. This is mostly adaptive: it lets you function without re-deriving the world from scratch each morning. But it has a cost. The same machinery produces the rigid, low-entropy states the Mental Health section describes, the locked rumination of depression, the grooves of addiction, the loops of OCD, the calcified self-story that no insight seems able to budge. The brain has, in a sense, over-tightened.

Classic psychedelics (psilocybin, LSD, DMT, mescaline) work primarily by stimulating the serotonin 2A receptor, and the system-level effect is to raise the brain’s entropy: to relax the grip of those high-level priors, loosen the rigid networks, and push the brain toward what physicists call criticality, the rich, flexible state poised between order and chaos where information flows most freely. The default mode network, the seat of the self-model and the narrating “I” described in Mystical Experiences & the Nervous System, disintegrates and decouples, and as the self-model loosens, the experience of a bounded ego loosens with it. Ego dissolution is, mechanistically, the temporary relaxation of the brain’s most fundamental prior: the assumption that there is a separate self at the centre of experience.

Two consequences follow, and they are the source of both the promise and the peril:

  • The system becomes plastic: Raising entropy and relaxing the priors opens a window of heightened neuroplasticity, a period in which entrenched patterns become temporarily revisable. The brain is, briefly, able to be rewired, which is why a single experience can sometimes shift a depression or a habit that years of effort could not.
  • The constraints that normally protect you also relax: The same loosening that frees a stuck mind removes the guardrails that keep experience bounded and tolerable. Buried material surfaces, the sense of self can vanish frighteningly, and the brain’s reduced reality-testing means whatever arises feels utterly, unquestionably real. This is the mechanism behind both breakthroughs and breakdowns.

Psychedelics are entropy amplifiers, not wisdom-makers. They do not instil insight or virtue. They open a plastic, high-entropy window, and what happens in and after that window, what surfaces, how it is held, and what is done with it, is everything. The drug supplies the openness; you and your circumstances supply the content and the meaning.

 

II. The Compounds

  • Psilocybin (mushrooms): the most studied, with a several-hour arc, a relatively gentle on-ramp, and the largest clinical-trial base (depression, end-of-life distress, addiction). The reference compound for most of the research above.
  • LSD: longer (eight to twelve hours), similar mechanism, more cognitively “electric”; the length raises the stakes of a difficult experience.
  • DMT and ayahuasca: DMT is brief and overwhelmingly intense (the “breakthrough” is minutes long); ayahuasca is the Amazonian brew combining DMT with an MAO inhibitor to make it orally active, producing a several-hour journey, traditionally in ceremony, often with purging, and carrying genuine drug-interaction dangers (the MAO inhibitor interacts dangerously with certain medications, notably SSRIs and others, and some foods).
  • 5-MeO-DMT (from the Sonoran Desert toad or synthesised): a different beast, less visionary, more a rapid, total annihilation of the self, the most extreme ego-dissolution experience available, and correspondingly the least forgiving for the unprepared. Its intensity is not a measure of its value, and it warrants the most caution and the most experienced support.
  • Mescaline (peyote, San Pedro): long, classically visionary, with deep indigenous ceremonial roots.

The intensity of an experience is not its worth. The Western culture’s tendency to treat 5-MeO-DMT or a “heroic dose” as more advanced or more valuable is exactly the state-chasing error from the previous page. The deepest annihilation of the self is not automatically the most useful event for the life it returns to.

 

III. The Promise

Psilocybin therapy has produced rapid and sometimes durable reductions in treatment-resistant depression, in the anxiety and depression of people facing terminal illness (where a single session can substantially relieve the fear of death), and in addictions to alcohol and tobacco where conventional treatment had failed. The entropic-brain mechanism explains why: a rigid, low-entropy pathology met with a temporary high-entropy, high-plasticity window in which the locked pattern can finally be revised. These are not yet settled, approved, first-line treatments; the trials are maturing, some effects may be inflated by expectancy and the difficulty of blinding, and the durability varies, but the signal is legit, and the mechanism is coherent.

Beyond the clinic, the experiences people report, dissolution of a lifelong sense of separateness, a felt reconciliation with death, a flood of connection and meaning, a vantage from which a stuck life suddenly looks changeable, are real psychological events with real aftereffects, and dismissing them as “just chemistry” is the category error the section overview warns against. 

 

IV. The Risks

  • Psychiatric vulnerability: In people with, or predisposed to, psychosis, schizophrenia, or bipolar disorder, psychedelics can trigger or worsen psychosis or mania, sometimes lastingly. A personal or strong family history here is the clearest reason not to use classic psychedelics, and it is not a matter of willpower or preparation. This is the single most important screen.
  • Drug interactions can be dangerous: Ayahuasca’s MAO inhibitor interacts dangerously with SSRIs, certain other antidepressants and medications, and some foods (risking serotonin syndrome or hypertensive crisis). Lithium combined with psychedelics has been linked to seizures. Anyone on psychiatric or other medication needs to know the specific interactions before going near these compounds.
  • The difficult experience: Terror, paranoia, the conviction of going mad or having died, can dominate a session, and while a well-handled hard experience can still be valuable, a badly-handled one can be traumatic. Set and setting (below) exist precisely to manage this.
  • Lasting perceptual effects: A minority develop hallucinogen persisting perception disorder (HPPD), ongoing visual disturbances after the experience has ended; uncommon, but real.
  • Destabilisation and “spiritual emergency”: As the previous page detailed, the loosening can tip a vulnerable person into a prolonged crisis that the surrounding culture may misread as awakening, delaying needed help.
  • Physical cautions: Certain compounds raise heart rate and blood pressure (a cardiac consideration); 5-MeO-DMT and DMT are physically intense; and the unregulated supply means dosing and purity are real hazards.
  • They are illegal in most places: A risk in itself (legal, and in the case of adulterated supply, physical), and a fact to factor in rather than pretend away.

 

V. Use, Not Abuse

  • Screen yourself: The psychiatric-vulnerability and medication-interaction cautions above are the gatekeepers. If they apply to you, this is not your tool, and that is a clear-eyed safety decision, not a failure of courage.
  • Set and setting are not optional: Set (your mindset, intention, and emotional state going in) and setting (the physical and social environment) shape the experience more than the dose. A grounded intention, a safe and comfortable space, and trusted, sober people present transform the risk profile. This is the single highest-leverage harm-reduction principle, established since the earliest research.
  • A sober sitter, and ideally an experienced guide: Someone present, sober, and trusted to keep you physically safe and calmly reassure you changes everything, especially for the intense compounds. The therapeutic trials are built around exactly this.
  • Respect dose, and do not chase intensity: Start low. The cultural worship of heroic doses and the most annihilating compounds is the state-chasing trap; more intensity is not more value, and it is more risk.
  • Test your substances: Given the unregulated supply, reagent testing and known sourcing are basic physical safety.
  • Integration is where the value is made, or lost: This is the heart of it, and the part the culture most neglects. The experience opens the plastic window; integration is the work of turning what surfaced into lasting change, through reflection, journaling, therapy, conversation, and above all changed behaviour in ordinary life. As the Spiritual Bypassing page argued, an experience that alters only your self-image while leaving your life untouched is worse than useless; it is a new way to avoid yourself. The neuroplastic window closes within days to weeks; what you build in it is what remains.
  • Don’t overuse: Frequent use erodes the value (tolerance builds fast, and the experiences blur), and compulsive journeying is its own escapism, the same dead end as compulsive retreat-going. Once you receive the message, hang up the phone. 

 

VI. The Ego Death Trap

A final discernment, because it is where this route most often goes wrong in hyper-spiritual culture. “Ego death” gets worn as a badge, the trophy from a journey, evidence of attainment, and that is precisely the inversion the section overview warned of: the ego claiming the dissolution of the ego as one more achievement. As that page argued, the self-model is necessary scaffolding; the goal is not its permanent destruction but the flexibility to loosen it and return. A psychedelic can show you, viscerally, that the self is more provisional and constructed than it feels, which is a genuine and potentially liberating insight. But the insight has to be integrated into a more flexible, less defended way of living. When instead it becomes a story (“I’ve died and been reborn, I’m awakened now”) laid over the same unchanged personality and conduct, the ego has not dissolved; it has been upgraded with better branding. And the “chemically unburdened” question returns with full force: feeling free of the self for an afternoon is not the same as being freed, and mistaking the first for the second is how people collect profound experiences while their actual lives, and the people in them, stay exactly as they were.

These are tools with real promise and real danger that amplify entropy rather than dispense wisdom. Take the experiences seriously, take the risks seriously, hold the content lightly, and judge the whole thing by one test alone, not how transcendent it felt, but whether the life it returned you to is measurably more present, freer, and kinder. That is the difference between an awakening and an afternoon off from yourself.

 

VII. Cross-Links

Resources

  • Carhart-Harris, R. L., et al. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience, 8, 20.
  • Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316–344.
  • Carhart-Harris, R. L., et al. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. PNAS, 109(6), 2138–2143. (DMN disintegration and ego dissolution.)
  • Griffiths, R. R., et al. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. Journal of Psychopharmacology, 30(12).
  • Carhart-Harris, R. L., et al. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411.
  • Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620. (The set, setting, screening, and harm-reduction basis.)